REGEN BIOPHARMA, INC. Proceeds from (Repayments of) Secured Debt
REGEN BIOPHARMA, INC. (RGBP) reported Proceeds from (Repayments of) Secured Debt of $0 for the 6-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfSecuredDebt · last filed 2026-05-14
- REGEN BIOPHARMA, INC. proceeds from (repayments of) secured debt for the quarter ending 2026-03-31 was $0.00.
- REGEN BIOPHARMA, INC. proceeds from (repayments of) secured debt for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- REGEN BIOPHARMA, INC. proceeds from (repayments of) secured debt for the quarter ending 2025-03-31 was -$65.80K, a 280.27% decline year-over-year.
- REGEN BIOPHARMA, INC. proceeds from (repayments of) secured debt for the quarter ending 2024-12-31 was $65.80K.
- REGEN BIOPHARMA, INC. proceeds from (repayments of) secured debt for fiscal 2025 was $194.60K.
- REGEN BIOPHARMA, INC. proceeds from (repayments of) secured debt for fiscal 2024 was -$10.00K.
| Period end | Proceeds from (Repayments of) Secured Debt 3 month | Proceeds from (Repayments of) Secured Debt 6 month | Proceeds from (Repayments of) Secured Debt 9 month | Proceeds from (Repayments of) Secured Debt 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-14 | $0.00 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $0.00 10-Q · filed 2026-02-13 | |||
| 2025-09-30 | $194.60K 10-K · filed 2025-12-30 | |||
| 2025-03-31 | -$65.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-14 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 3 quarters · filed 2026-05-14 | $0.00 derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $65.80K 10-Q · filed 2026-02-13 | $65.80K derived: sum of 2 quarters · filed 2026-02-13 | $65.80K derived: sum of 3 quarters · filed 2026-02-13 | $102.30K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-30 | $0.00 derived: sum of 2 quarters · filed 2025-12-30 | $36.50K derived: sum of 3 quarters · filed 2025-12-30 | -$10.00K 10-K · filed 2025-12-30 |
| 2024-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-11 | $36.50K derived: sum of 2 quarters · filed 2025-08-11 | -$10.00K 10-Q · filed 2025-08-11 | |
| 2024-03-31 | $36.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-28 | -$10.00K 10-Q · filed 2025-05-28 | ||
| 2023-12-31 | -$46.50K 10-Q · filed 2025-05-16 |